Adopted Sections An agency may take final action on a section 30 days after a proposal has been published in the Texas Register. The section becomes effective 20 days after the agency files the correct document with the Texas Register, unless a later date is specified or unless a federal statute or regulation requires implementation of the action on shorter notice. If an agency adopts the section without any changes to the proposed text, only the preamble of the notice and statement of legal authority will be published. If an agency adopts the section with changes to the proposed text, the proposal will be republished with the changes. TITLE 22. EXAMINING BOARDS Part IX. Texas State Board of Medical Examiners Chapter 161. General Provisions 22 TAC sec.161.1 The Texas State Board of Medical Examiners adopts an amendment to sec.161. 1, without changes to the proposed text as published in the May 18, 1993, issue of the Texas Register (18 TexReg 3238). The amendment will clarify the duties of the Board committees. The amendment will function by providing guidelines for committee members. No comments were received regarding adoption of the amendment. The amendment is adopted under Texas Civil Statutes, Article 4495b, which provide the Texas State Board of Medical Examiners with the authority to make rules, regulations, and bylaws not inconsistent with this Act as may be necessary for the governing of its own proceedings, the performance of its duties, the regulation of the practice of medicine in this state, and the enforcement of this Act. This agency hereby certifies that the rule as adopted has been reviewed by legal counsel and found to be a valid exercise of the agency's legal authority. Issued in Austin, Texas, on June 21, 1993. TRD-9324960 Homer R. Goehrs, M.D. Executive Director Texas State Board of Medical Examiners Effective date: July 20, 1993 Proposal publication date: May 18, 1993 For further information, please call: (512) 834-4502 Chapter 163. Licensure 22 TAC sec.163.9 The Texas State Board of Medical Examiners adopts an amendment to sec.163. 9, without changes to the proposed text as published in the April 20, 1993, issue of the Texas Register (18 TexReg 2510). The amendment allows an additional examination to be considered in lieu of the Special Purpose Examination for reciprocal endorsement applicants not examined within the past ten years. The amendment will function by allowing physicians who have training equal to that required for specialty certification to be considered for licensure, without the necessity of taking the Special Purpose Examination. No comments were received regarding adoption of the amendment. The amendment is adopted under Texas Civil Statutes, Article 4495b, which provide the Texas State Board of Medical Examiners with the authority to make rules, regulations, and bylaws not inconsistent with this Act as may be necessary for the governing of its own proceedings, the performance of its duties, the regulation of the practice of medicine in this state, and the enforcement of this Act. This agency hereby certifies that the rule as adopted has been reviewed by legal counsel and found to be a valid exercise of the agency's legal authority. Issued in Austin, Texas, on June 21, 1993. TRD-9324959 Homer R. Goehrs, M.D. Executive Director Texas State Board of Medical Examiners Effective date: July 20, 1993 Proposal publication date: April 20, 1993 For further information, please call: (512) 834-4502 Chapter 179. Investigation Files 22 TAC sec.179.2 The Texas State Board of Medical Examiners adopts an amendment to sec.179. 2, without changes to the proposed text as published in the May 18, 1993, issue of the Texas Register (18 TexReg 3240). The adopted amendment will clarify the rules regarding information needed for investigation files. The amendment will function by clearly defining the information to be submitted by physicians regarding medical records. No comments were received regarding adoption of the amendment. The amendment is adopted under Texas Civil Statutes, Article 4495b, which provide the Texas State Board of Medical Examiners with the authority to make rules, regulations, and bylaws not inconsistent with this Act as may be necessary for the governing of its own proceedings, the performance of its duties, the regulation of the practice of medicine in this state, and the enforcement of this Act. This agency hereby certifies that the rule as adopted has been reviewed by legal counsel and found to be a valid exercise of the agency's legal authority. Issued in Austin, Texas, on June 21, 1993. TRD-9324961 Homer R. Goehrs, M.D. Executive Director Texas State Board of Medical Examiners Effective date: July 20, 1993 Proposal publication date: May 18, 1993 For further information, please call: (512) 834-4502 22 TAC sec.179.6 The Texas State Board of Medical Examiners adopts an amendment to sec.179. 6, without changes to the proposed text as published in the April 20, 1993, issue of the Texas Register (18 TexReg 2511). The amendment will clarify the physician's responsibility in reporting professional liability claims. The amendment will function by giving examples of those claims that are not required to be reported and by reducing the amount of paperwork regarding the reporting of unnecessary claims. One comment was received proposing a future amendment to this section; however, the comment did not relate to the current amendment. The amendment is adopted under Texas Civil Statutes, Article 4495b, which provide the Texas State Board of Medical Examiners with the authority to make rules, regulations, and bylaws not inconsistent with this Act as may be necessary for the governing of its own proceedings, the performance of its duties, the regulation of the practice of medicine in this state, and the enforcement of this Act. This agency hereby certifies that the rule as adopted has been reviewed by legal counsel and found to be a valid exercise of the agency's legal authority. Issued in Austin, Texas, on June 21, 1993. TRD-9324962 Homer R. Goehrs, M.D. Executive Director Texas State Board of Medical Examiners Effective date: July 20, 1993 Proposal publication date: April 20, 1993 For further information, please call: (512) 834-4502 Chapter 187. Procedure Subchapter D. Posthearing 22 TAC sec.sec.187.31, 187.32, 187.34, 187.36 The Texas State Board of Medical Examiners adopts amendments to sec.sec.187. 31, 187.32, 187.34, and 187.36, without changes to the proposed text as published in the April 20, 1993, issue of the Texas Register (18 TexReg 2513). The amendments will allow the Board flexibility in rendering a decision on disciplinary matters when it is in the best interest of the public. The amendments will establish policy reasons, or legal grounds, to enable the Board to disagree with the recommendation of the administrative law judge on proposals for decision. One comments was received questioning the necessity of the change in sec.187. 34(d). An attorney commented against the adoption of sec.187.34(d). The agency disagreed with the comment because it amounted to criticism of form of rule and not substance. The substance of the rule is significant enough to avoid delay based on a criticism of the form of the rule, and no action was taken as a result of the comment. The amendments are adopted under Texas Civil Statutes, Article 4495b, which provide the Texas State Board of Medical Examiners with the authority to make rules, regulations, and bylaw not inconsistent with this Act as may be necessary for the governing of its own proceedings, the performance of its duties, the regulation of the practice of medicine in this state, and the enforcement of this Act. This agency hereby certifies that the rule as adopted has been reviewed by legal counsel and found to be a valid exercise of the agency's legal authority. Issued in Austin, Texas, on June 21, 1993. TRD-9324963 Homer R. Goehrs, M.D. Executive Director Texas State Board of Medical Examiners Effective date: July 20, 1993 Proposal publication date: April 20, 1993 For further information, please call: (512) 834-4502 Chapter 199. Disciplinary Hearings Panels 22 TAC sec.sec.199.1-199.5 The Texas State Board of Medical Examiners adopts the repeal of sec.sec.199. 1-199.5, without changes to the proposed text as published in the April 20, 1993, issue of the Texas Register (18 TexReg 2514). The adopted repeal is necessary due to a change in law establishing the State Office Administrative Hearings to handle all contested cases. The section will function by deletion. No comments were received regarding adoption of the repeals. The repeals are adopted under Texas Civil Statutes, Article 4495b, which provide the Texas State Board of Medical Examiners with the authority to make rules, regulations, and bylaws not inconsistent with this Act as may be necessary for the governing of its own proceedings, the performance of its duties, the regulation of the practice of medicine in this state, and the enforcement of this Act. This agency hereby certifies that the rule as adopted has been reviewed by legal counsel and found to be a valid exercise of the agency's legal authority. Issued in Austin, Texas, on June 21, 1993. TRD-9324964 Homer R. Goehrs, M.D. Executive Director Texas State Board of Medical Examiners Effective date: July 20, 1993 Proposal publication date: April 20, 1993 For further information, please call: (512) 834-4502 TITLE 25. HEALTH SERVICES Part I. Texas Department of Health Chapter 229. Food and Drug Synthetic Narcotic Drugs in the Treatment of Drug Dependent Persons 25 TAC sec.229.148 The Texas Department of Health (department) adopts an amendment to sec.229.148, concerning Minimum Standards for Approved Drug Treatment Programs, with changes to the proposed text as published in the May 11, 1993, issue of the Texas Register (18 TexReg 3014). The amendment establishes licensing and operating requirements for narcotic treatment programs pursuant to the requirements of Chapter 466 of the Texas Health and Safety Code and the rules adopted thereunder entitled "Minimum Standards for Approved Narcotic Drug Treatment Programs." The amendment will require yearly tuberculosis screening tests utilizing the Mantoux technique for narcotic treatment program patients and employees. The following comments were received relating to the proposed amendments. COMMENT: Several commenters stated that HIV-positive patients who have a negative reaction to the tuberculin screening test should receive anergy screening. RESPONSE: The department agrees and has made changes to the final sec.229. 148(u). COMMENT: Several commenters stated that tuberculosis screening tests should be required every 6 months. RESPONSE: The department feels that annual testing is sufficient but will reevaluate this recommendation after 1 year to determine if semi-annual testing would be advantageous. COMMENT: One commenter stated that anergy testing should be required for all patients who are found to be tuberculin-negative because of the increased incidence of anergy among IV drug users and the unknown incidence of HIV infection among program patients. RESPONSE: The department has insufficient data at this time to amend the section to reflect this change but will gather information relevant to this request in order to assess feasibility of this requirement. The commenters were the Bureau of Disease Control and Epidemiology at the Texas Department of Health, the University of Texas Health Science Center at Houston, and several individuals. None of the commenters were totally for or against the sections, but they had concerns, recommendations, and questions. The amendments are adopted under Texas Health and Safety Code, sec.466.004, which provides the department with the authority to adopt necessary regulations pursuant to the enforcement of this Chapter; and sec.12.001, which provides the Texas Board of Health with the authority to adopt rules for the performance of every duty imposed by law on the Texas Board of Health, the Texas Department of Health and the Commissioner of Health. sec.229.148. State Operational Requirements. (a)-(t) (No change.) (u) Upon admission, each patient must receive an intradermal skin test using the Mantoux technique, or, when available, a procedure of equal or better sensitivity. A patient is not required to be retested at each admission if he or she can provide documentation that a Mantoux test was performed within the previous 12 months. Patients who had negative tuberculin skin tests on admission must be retested each year. Patients with a positive skin test result of five millimeters or greater must be referred for diagnostic evaluation. HIV seropositive patients found to be tuberculin-negative must be tested for anergy. Anergic HIV-positive patients must be referred for clinical assessment and possible preventative therapy. (v) Each employee working in a narcotic treatment program must receive an intradermal skin test using the Mantoux technique at the start of employment and annually thereafter, or present a certificate signed by a physician that states that: (1) the employee has been tested for tuberculosis infection within the previous 90 days; and (2) the results of the test indicates that the person does not have tuberculosis. (w) In lieu of a screening test an employee with a history of a positive screening test must provide: (1) documentation of that positive test result and of any diagnostic and therapeutic follow-up; and (2) a certificate signed by a physician that states that the person does not have tuberculosis. (x) All notations by NTP personnel on patient files and other files kept by the NTP for purposes of this chapter shall be typed, printed, or legibly handwritten so that any regulatory authority could read the writing. (y) A NTP may not refuse to allow an inspection or otherwise interfere with personnel of the State Methadone Authority in the performance of their duties, including the photocopying of patient records during an inspection. It is a violation for a NTP not to fully cooperate in any inspection by the State Methadone Authority. (z) Each NTP shall notify the State Methadone Authority in writing of any change in the employment status of any of its program personnel. This notice shall be provided within 20 days of the event. (aa) NTP counselors not exempted must be licensed by the Texas Commission on Alcohol and Drug Abuse (TCADA). (bb) Any theft from or illegal break-in to the clinic must be reported in writing to the State Methadone Authority within 10 days of the event. This agency hereby certifies that rule as adopted has been reviewed by legal counsel and found to be within the agency's authority to adopt. Issued in Austin, Texas, on June 28, 1993. TRD-9324915 Robert A. MacLean, M.D. Deputy Commissioner Texas Department of Health Effective date: July 29, 1993 For further information, please call: (512) 458-7248 Registration of Manufacturers of Food-Including Good Manufacturing Practices 25 TAC sec.229.182, sec.229.183 The Texas Department of Health (department) adopts amendments to sec.229.182 and sec.229. 183, concerning registration fee and procedures; and minimum standards for registration of manufacturing of food-including good manufacturing practices, without change to the proposed text as published in the May 11, 1993, issue of the Texas Register (18 TexReg 3015). The amendments will enable the department to register and regulate manufacturers of food so as to ensure compliance with the federal regulations titled "Current Good Manufacturing Practice in Manufacturing, Packing, or Holding Human Food." The changed deadlines will enable the department to process the registrations in a more timely manner, help reduce the massive peak workload which results from processing over 9,200 food and drug applications at the same time, eliminate the need for temporary workers to assist with registration, and afford the department more time to follow up on firms that are delinquent in fee payment. No comments were received relating to the proposed amendments. The amendments are adopted under the Texas Health and Safety Code, sec.431. 241, which provides the department with the authority to adopt necessary regulations pursuant to the enforcement of this chapter; sec.431.225, which provides the Board the authority to adopt regulations to provide that registrations may expire at different dates during the year and to prorate registration fees payable on or before September 1 so that each registrant is required to pay only that portion of the registration fee allocable to the number of months during which the registration is valid ; and sec.12.001, which provides the Texas Board of Health with the authority to adopt rules for the performance of every duty imposed by law on the Texas Board of Health, the Texas Department of Health, and the Commissioner of Health. This agency hereby certifies that the rule as adopted has been reviewed by legal counsel and found to be a valid exercise of the agency's legal authority. Issued in Austin, Texas, on June 28, 1993. TRD-9324977 Robert A. MacLean, M.D. Deputy Commissioner Texas Department of Health Effective date: July 20, 1993 Proposal publication date: May 11, 1993 For further information, please call: (512) 458-7248 Licensing of Wholesale Distributors of Drugs-Including Good Manufacturing Practices 25 TAC sec.229.252 The Texas Department of Health (department) adopts an amendment to sec.229.252, concerning licensing fees and procedures for wholesale distributors of drugs-including good manufacturing practices, with changes to the proposed text as published in the May 11, 1993, issue of the Texas Register (18 TexReg 3016). The amendment will enable the department to license and regulate wholesale distributors of drugs so as to ensure compliance with the federal regulations entitled "Current Good Manufacturing Practice in Manufacturing, Processing, Packing, or Holding of Drugs; General." The changed deadlines will enable the department to process the applications in a more timely and efficient manner, help reduce the massive peak workload which results from processing over 1,600 drug applications at the same time, eliminate the need for temporary workers to assist with registration, and afford the department more time to follow up on firms that are delinquent in fee payment. No comments were received; however, the department felt clarification was needed as to the requirements necessary to amend licenses. The department has included the necessary language in sec.229.252(g)(3)(A) which will clarify the intent of the statute. The amendment is adopted under the Texas Health and Safety Code, sec.431.241, which provides the department with the authority to adopt necessary regulations pursuant to the enforcement of this chapter; sec.431.205, which provides the Board the authority to adopt regulations to provide that licenses may expire on different dates during the year and to prorate license fees payable on or before September 1 so that the licensee is required to pay only that portion of the fee that is allocable to the number of months during which the license is valid; and sec.12.001, which provides the Texas Board of Health with the authority to adopt rules for the performance of every duty imposed by law on the Texas Board of Health, the Texas Department of Health, and the Commissioner of Health. sec.229.252. Licensing Fee and Procedures. (a) License fee. All wholesale distributors of drugs who sell drugs in Texas shall obtain a license annually with the Texas Department of Health (department) and shall pay a licensing fee for each wholesale distribution place of business operated as follows: (1)-(5) (No change.) (b)-(e) (No change.) (f) Issuance of license. The department may license a wholesale distributor of drugs who meets the requirements of this section and sec.229.253 of this title (relating to Minimum Standards for Licensing). (1) The initial license shall be valid for one year from the date of issuance which becomes the anniversary date. (2) The renewal license shall be valid for one year from the anniversary date. (g) Renewal of license. (1) Each year, the wholesale distributor of drugs shall renew its license following the requirements of this section and sec.229.253 of this title (relating to Minimum Standards for Licensing). (2) A person who holds a license issued by the department under the Health and Safety Code shall renew the license by filing an application for renewal on a form prescribed by the Department, accompanied by the appropriate licensure fee. A licensee must file for renewal before the expiration date of the current license. A person who files a renewal application after the expiration date must pay an additional $100 as a delinquency fee. (3) Failure to submit the renewal annually may subject the wholesale distributor of drugs to the enforcement provisions under Health and Safety Code, Chapter 431, and to the provisions of sec.229.254 of this title (relating to Refusal, Revocation, or Suspension of License). (A) Amendment of license. A license that is amended, including a change of name, ownership, or a notification of a change in the location of a licensed place of business required under the Health and Safety Code, sec.431.206, will require submission of fees as outlined in subsection (a) of this section. (B) Notification of change of location of place of business. Not fewer than 30 days in advance of the change, the licensee shall notify the Commissioner of Health (commissioner) or the commissioner's designee in writing of the licensee's intent to change the location of a licensed place of business. The notice shall include the address of the new location, and the name and residence address of the individual in charge of the business at the new location. Not more than 10 days after the completion of the change of location, the licensee shall notify the commissioner or the commissioner's designee in writing to verify the change of location, the address of the new location, and the name and residence address of the individual in charge of the business at the new address. Notice will be deemed adequate if the licensee provides the intent and verification notices to the commissioner or the commissioner's designee by certified mail, return receipt requested, mailed to the Texas Department of Health, 1100 West 49th Street, Austin. (h) Exemption from licensing. Persons who engage only in the following types of wholesale drug distribution are exempt from the licensing requirements of this undesignated head, to the extent that it does not violate provisions of the Texas Dangerous Drug Act or the Texas Controlled Substances Act, the Health and Safety Code: (1) intracompany sales; (2) the purchase or acquisition by a hospital or other health care entity that is a member of a group purchasing organization of a drug for its own use from the group purchasing organization or from other hospitals or health care entities that are members of such organizations; (3) the sale, purchase, or trade of a drug or an offer to sell, purchase, or trade a drug by a charitable organization, as described in the Internal Revenue Code of 1986, sec.501(c)(3), to a nonprofit affiliate of the organization to the extent otherwise permitted by law; (4) the sale, purchase, or trade of a drug or an offer to sell, purchase, or trade a drug among hospitals or other health care entities that are under common control. For the purpose of this subsection, "common control" means the power to direct or cause the direction of the management and policies of a person or an organization, whether by ownership of stock, voting rights, contract, or otherwise; (5) the sale, purchase, or trade of a drug or an offer to sell, purchase, or trade a drug for emergency medical reasons. For purposes of this section, "emergency medical reasons" includes transfers of prescription drugs by a retail pharmacy to another retail pharmacy to alleviate a temporary shortage; (6) the sale, purchase, or trade of a drug, an offer to sell, purchase, or trade a drug, or the dispensing of a drug pursuant to a prescription; (7) the distribution of drug samples by manufacturers' representatives or distributors' representatives; or (8) the sale, purchase, or trade of blood and blood components intended for transfusion. This agency hereby certifies that the rule as adopted has been reviewed by legal counsel and found to be a valid exercise of the agency's legal authority. Issued in Austin, Texas, on June 29, 1993. TRD-9324976 Robert A. MacLean, M.D. Deputy Commissioner Texas Department of Health Effective date: July 20, 1993 Proposal publication date: May 11, 1993 For further information, please call: (512) 458-7248